© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
All News
ViiV Healthcare Receives FDA Approval for Drug to Treat Adults with HIV-1
August 08, 2020
Dovato allows adults living with HIV to reduce the number of antiretroviral therapies they take each day, while maintaining efficacy and high barrier to resistance comparable to tenofovir-based regimens of at least three drugs
Researcher Adam Block: Health Plans Are ‘Rolling in Money’ As Providers, Rest of Economy Struggle
August 07, 2020
In this part one of two video series, Adam Block, a New York Medical College assistant professor, discusses his recent contributed article to Managed Healthcare Executive titled "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates."
NIAID Launching RCT of Rebif-Remdesivir Combination as Treatment for COVID-19
August 07, 2020
Double-blind study will compare Rebif-remdesivir combination with remdesivir-alone in hospitalized COVID-19 patients
Monarch Medical Technologies Appoints Raymie McFarland as President and CEO
August 07, 2020
The highly respected healthcare industry veteran will bring his signature team building skills, track record of double-digit revenue growth and subject matter expertise in diabetes.
Fallon Chief Medical Officer Carolyn Langer Says Real-Time Notification Makes All the Difference
August 06, 2020
In this part two of two series, Carolyn Langer, M.D., Fallon Health's chief medical officer, talks about Collective Medical and the advantages of real-time notifications of member hospital admissions and discharges and emergency department visits.
Adam Block of New York Medical College Speaks on Profits of Health Plans
August 06, 2020
This week on Tuning Into The C-Suite, Managed Healthcare Executive Senior Editor Peter Wehrwein speaks with Assistant Professor of Public Health at New York Medical College, Adam Block. The two discuss Block's recent article published in MHE, "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates" and more.
Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates
August 06, 2020
Amid struggling providers, furloughs of essential workers, years of premium increases and record high earnings, for-profit health plans should consider options for directly helping their networks.
NEJM study: Caps on out-of-pocket costs for specialty drugs reduce patient spend by 32%
August 06, 2020
Research model shows that caps on out-of-pocket costs don't result in higher health plan spending
How Fallon Health Has Coped With COVID-19
August 05, 2020
In this part one of two series, Carolyn Langer, M.D., the chief medical officer, says the Massachusetts health plan mounted a big push on telehealth that includes in-person visit payment levels.
An Update for Cardiologists Who See Patients With Type 2 Diabetes
August 05, 2020
The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.